1. Home
  2. SAGE vs MTW Comparison

SAGE vs MTW Comparison

Compare SAGE & MTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAGE
    SELLHOLDBUYas of 14 hours ago
  • MTW
    SELLHOLDBUYas of 14 hours ago
  • Stock Information
  • Founded
  • SAGE 2010
  • MTW 1902
  • Country
  • SAGE United States
  • MTW United States
  • Employees
  • SAGE N/A
  • MTW N/A
  • Industry
  • SAGE Biotechnology: Pharmaceutical Preparations
  • MTW Construction/Ag Equipment/Trucks
  • Sector
  • SAGE Health Care
  • MTW Industrials
  • Exchange
  • SAGE Nasdaq
  • MTW Nasdaq
  • Market Cap
  • SAGE 462.2M
  • MTW 374.8M
  • IPO Year
  • SAGE 2014
  • MTW N/A
  • Fundamental
  • Price
  • SAGE $5.43
  • MTW $9.14
  • Analyst Decision
  • SAGE Hold
  • MTW Sell
  • Analyst Count
  • SAGE 19
  • MTW 6
  • Target Price
  • SAGE $11.53
  • MTW $12.47
  • AVG Volume (30 Days)
  • SAGE 1.4M
  • MTW 279.2K
  • Earning Date
  • SAGE 02-12-2025
  • MTW 02-12-2025
  • Dividend Yield
  • SAGE N/A
  • MTW N/A
  • EPS Growth
  • SAGE N/A
  • MTW N/A
  • EPS
  • SAGE N/A
  • MTW N/A
  • Revenue
  • SAGE $106,399,000.00
  • MTW $2,177,800,000.00
  • Revenue This Year
  • SAGE N/A
  • MTW N/A
  • Revenue Next Year
  • SAGE $122.66
  • MTW $1.55
  • P/E Ratio
  • SAGE N/A
  • MTW N/A
  • Revenue Growth
  • SAGE 837.60
  • MTW N/A
  • 52 Week Low
  • SAGE $4.62
  • MTW $8.50
  • 52 Week High
  • SAGE $28.26
  • MTW $17.65
  • Technical
  • Relative Strength Index (RSI)
  • SAGE 46.96
  • MTW 42.31
  • Support Level
  • SAGE $5.24
  • MTW $8.54
  • Resistance Level
  • SAGE $5.97
  • MTW $9.07
  • Average True Range (ATR)
  • SAGE 0.42
  • MTW 0.38
  • MACD
  • SAGE 0.04
  • MTW -0.04
  • Stochastic Oscillator
  • SAGE 47.57
  • MTW 35.47

Stock Price Comparison Chart: SAGE vs MTW

SAGE
MTW
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober0102030405060708090100SAGE VS MTW

About SAGE Sage Therapeutics Inc.

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.

About MTW Manitowoc Company Inc. (The)

Manitowoc Co Inc provides engineered lifting solutions. It designs and manufactures mobile telescopic cranes, tower cranes, lattice-boom crawler cranes, and boom trucks. It offers products under brand names such as Grove, Manitowoc, National Crane, Potain, Shuttlelift, and Manitowoc Crane Care. Its crane products serve dealers, rental companies, contractors, and government entities in diverse markets, including energy production/distribution and utility, petrochemical and industrial, infrastructure, and commercial/residential construction. Manitowoc has three reportable segments: the Americas, Europe and Africa, and the Middle East and Asia-Pacific. The Americas segment generates the majority of the revenue for the company.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use